After potential rabies exposure, the Anti-Rabies Post-Exposure Prophylaxis prevents virus progression. Visit Surevax nearest you.
Learn more about:
Recommended for: People who are regularly exposed to animals that could have rabies, like dogs or cats.
Disease prevented: Rabies
Price:
₱800.00
The Anti-Rabies Post-Exposure Prophylaxis (PEP) is administered after a potential rabies exposure to prevent the virus from progressing within the body. It triggers the immune system to fight off the rabies virus before it can spread to vital organs, where it becomes life-threatening.
₱800.00
The Anti-Rabies post-exposure vaccine is administered after an individual has been potentially exposed to the rabies virus through animal bites, scratches, or saliva contact with open wounds. It stimulates the immune system to produce antibodies that fight off the virus, preventing it from spreading to the central nervous system where it can be fatal.
Find the Nearest SureVax Location:
Post-exposure vaccination is critical for individuals who have been bitten, scratched, or had exposure to saliva through broken skin or mucous membranes.
PEP includes a series of rabies vaccines, and in severe cases, rabies immunoglobulin (RIG) for immediate passive immunity.
PEP is safe and highly effective when administered promptly after exposure, with mild side effects like soreness or redness at the injection site.
Treatment depends on the severity of exposure and whether it fits into Category II (minor exposure) or Category III (severe exposure).
Should you get vaccinated? Who are high-risk individuals?
Individuals with minor scratches, abrasions without bleeding, or nibbling of uncovered skin. While these may seem mild, Category II exposures still present a risk of rabies infection and require immediate vaccination to prevent the virus from spreading.
Individuals with severe transdermal bites, puncture wounds, lacerations, or abrasions with bleeding, as well as exposure of broken skin or mucous membranes to infected saliva. This category also includes contact with bats, unprotected handling of infected carcasses, or contamination through body fluids. These high-risk cases demand prompt vaccination and rabies immunoglobulin (RIG) administration to ensure full protection.
Should you get vaccinated? Who are high-risk individuals?
Category II Exposure:
Individuals with minor scratches, abrasions without bleeding, or nibbling of uncovered skin. While these may seem mild, Category II exposures still present a risk of rabies infection and require immediate vaccination to prevent the virus from spreading.
Category III Exposure:
Individuals with severe transdermal bites, puncture wounds, lacerations, or abrasions with bleeding, as well as exposure of broken skin or mucous membranes to infected saliva. This category also includes contact with bats, unprotected handling of infected carcasses, or contamination through body fluids. These high-risk cases demand prompt vaccination and rabies immunoglobulin (RIG) administration to ensure full protection.
The Anti-Rabies (Post-Exposure) vaccine provides life-saving protection by preventing the development of rabies after potential exposure, ensuring safety and peace of mind.
Provides immediate defense, stopping the rabies virus from spreading within the body and preventing life-threatening infection.
Reduces the risk of severe complications, offering robust protection against the rabies virus.
Ensures individuals exposed to significant risks, such as bites or mucous membrane contact, receive life-saving treatment.
Protects individuals and prevents further rabies transmission within families and communities.
Provides reassurance to those exposed to rabies, ensuring a smooth recovery with effective treatment.
The Anti-Rabies (Post-Exposure) vaccine provides life-saving protection by preventing the development of rabies after potential exposure, ensuring safety and peace of mind.
Provides immediate defense, stopping the rabies virus from spreading within the body and preventing life-threatening infection.
Reduces the risk of severe complications, offering robust protection against the rabies virus.
Ensures individuals exposed to significant risks, such as bites or mucous membrane contact, receive life-saving treatment.
Protects individuals and prevents further rabies transmission within families and communities.
Provides reassurance to those exposed to rabies, ensuring a smooth recovery with effective treatment.
Find answers to common questions about the Anti-Rabies (Post-Exposure) vaccine, including when it’s needed and how it protects you.
PEP is a treatment involving anti-rabies vaccines and, in severe cases, rabies immunoglobulin (RIG) administered after rabies exposure to prevent infection.
Individuals with Category II or III rabies exposures, such as bites, scratches, or saliva contact with broken skin or mucous membranes, need immediate PEP.
PEP should begin as soon as possible after a suspected rabies exposure. Delays increase the risk of infection.
RIG provides immediate passive immunity for Category III exposures (severe bites, saliva in mucous membranes, etc.) while the vaccine helps build long-term immunity.
Yes, the rabies vaccine is safe, with mild side effects such as soreness at the injection site. Severe adverse effects are rare.
Missing a dose reduces vaccine effectiveness. Contact your healthcare provider immediately to reschedule and complete the series.
Wash the wound thoroughly with soap and water for at least 15 minutes, apply antiseptic, and seek immediate medical attention for PEP assessment.
Not all bites require PEP. A healthcare provider will assess the risk based on the type of exposure, animal behavior, and rabies status of the animal.
If the animal is observed for 10 days and shows no rabies symptoms, or tests negative, PEP can be discontinued under medical advice.
Find answers to common questions about the Anti-Rabies (Post-Exposure) vaccine, including when it’s needed and how it protects you.
PEP is a treatment involving anti-rabies vaccines and, in severe cases, rabies immunoglobulin (RIG) administered after rabies exposure to prevent infection.
Individuals with Category II or III rabies exposures, such as bites, scratches, or saliva contact with broken skin or mucous membranes, need immediate PEP.
PEP should begin as soon as possible after a suspected rabies exposure. Delays increase the risk of infection.
For most post-exposure cases, 4 doses are administered on Days 0, 3, 7, and 14.
RIG provides immediate passive immunity for Category III exposures (severe bites, saliva in mucous membranes, etc.) while the vaccine helps build long-term immunity.
Yes, the rabies vaccine is safe, with mild side effects such as soreness at the injection site. Severe adverse effects are rare.
Missing a dose reduces vaccine effectiveness. Contact your healthcare provider immediately to reschedule and complete the series.
Wash the wound thoroughly with soap and water for at least 15 minutes, apply antiseptic, and seek immediate medical attention for PEP assessment.
Not all bites require PEP. A healthcare provider will assess the risk based on the type of exposure, animal behavior, and rabies status of the animal.
If the animal is observed for 10 days and shows no rabies symptoms, or tests negative, PEP can be discontinued under medical advice.
It’s better to be safe than sorry.
Book your vaccination today!
The Anti-Rabies Pre-Exposure Prophylaxis (PrEP) is a preventive vaccination administered before potential rabies exposure. Visit Surevax nearest you.
Learn more about:
Recommended for: Individuals at higher risk of rabies exposure due to their profession, activities, or environment.
Disease prevented: Rabies
Price:
₱800.00
The Anti-Rabies Pre-Exposure Prophylaxis (PrEP) is a preventive vaccination administered before potential rabies exposure. It prepares the immune system to fight the rabies virus by producing antibodies, offering essential protection for individuals at elevated risk of encountering rabies-infected animals.
₱500.00
The Anti-Rabies Pre-Exposure Prophylaxis (PrEP) is a preventive vaccination administered before potential rabies exposure. It prepares the immune system to fight the rabies virus by producing antibodies, offering essential protection for individuals at elevated risk of encountering rabies-infected animals.
Find the Nearest SureVax Location:
The pre-exposure rabies vaccine helps individuals develop an immune response to the rabies virus before exposure occurs. This preemptive immunity reduces the risk of severe infection if bitten or scratched later.
Pre-exposure vaccination is especially recommended for people in high-risk occupations or living in rabies-endemic areas. It serves as a proactive measure to safeguard health.
The pre-exposure regimen involves 3 doses of the anti-rabies vaccine, typically given on Days 0, 7, and 21 or 28.
Even if vaccinated with PrEP, individuals still require post-exposure prophylaxis (PEP) following an animal bite but need fewer vaccine doses and no rabies immunoglobulin (RIG).
The vaccine is safe and well-tolerated, with minor side effects like redness or soreness at the injection site. Severe reactions are rare.
Should you get vaccinated? Who are high-risk individuals?
Individuals working closely with animals in veterinary clinics, wildlife rehabilitation centers, or laboratories handling rabies virus samples face frequent exposure risks. Pre-exposure vaccination ensures they have baseline immunity to protect against unexpected bites or contact with infected animals.
Farmers, hunters, forest rangers, and wildlife workers spend extended time in environments where contact with wild or stray animals is common. Pre-exposure vaccination reduces their risk of rabies infection during routine tasks.
Travelers visiting or staying for prolonged periods in rabies-endemic areas, especially where healthcare access is limited, benefit from pre-exposure vaccination. It provides essential protection against exposure while abroad and simplifies post-exposure treatment if needed.
Children, particularly those living in rabies-endemic regions, are more likely to play with animals or fail to report bites and scratches. Pre-exposure vaccination ensures they are protected against undetected exposures.
Professionals handling rabies virus samples or conducting rabies-related research are at high occupational risk. Pre-exposure vaccination provides critical protection during lab work.
Should you get vaccinated? Who are high-risk individuals?
Veterinarians, Animal Handlers, and Researchers
Individuals working closely with animals in veterinary clinics, wildlife rehabilitation centers, or laboratories handling rabies virus samples face frequent exposure risks. Pre-exposure vaccination ensures they have baseline immunity to protect against unexpected bites or contact with infected animals.
Wildlife Professionals and Outdoor Workers
Farmers, hunters, forest rangers, and wildlife workers spend extended time in environments where contact with wild or stray animals is common. Pre-exposure vaccination reduces their risk of rabies infection during routine tasks.
Travelers to
Rabies-Endemic Regions
Travelers visiting or staying for prolonged periods in rabies-endemic areas, especially where healthcare access is limited, benefit from pre-exposure vaccination. It provides essential protection against exposure while abroad and simplifies post-exposure treatment if needed.
Children Living in
High-Risk Areas
Children, particularly those living in rabies-endemic regions, are more likely to play with animals or fail to report bites and scratches. Pre-exposure vaccination ensures they are protected against undetected exposures.
Laboratory Workers
Professionals handling rabies virus samples or conducting rabies-related research are at high occupational risk. Pre-exposure vaccination provides critical protection during lab work.
The Anti-Rabies (Post-Exposure) vaccine provides life-saving protection by preventing the development of rabies after potential exposure, ensuring safety and peace of mind.
Reduces the severity of rabies exposure by ensuring the body can respond quickly and effectively if bitten.
Pre-vaccinated individuals require fewer post-exposure vaccine doses and no rabies immunoglobulin (RIG), making treatment faster and easier.
Essential for people regularly exposed to animals, ensuring ongoing protection without waiting for exposure to occur.
Travelers to rabies-endemic regions gain confidence in their safety, knowing they are protected even in remote locations with limited healthcare access.
Provides durable immunity with booster doses recommended every 3–5 years for individuals at continuous risk.
The Anti-Rabies (Pre-Exposure) vaccine provides life-saving protection by preventing the development of rabies before potential exposure, ensuring safety and peace of mind.
Reduces the severity of rabies exposure by ensuring the body can respond quickly and effectively if bitten.
Pre-vaccinated individuals require fewer post-exposure vaccine doses and no rabies immunoglobulin (RIG), making treatment faster and easier.
Essential for people regularly exposed to animals, ensuring ongoing protection without waiting for exposure to occur.
Travelers to rabies-endemic regions gain confidence in their safety, knowing they are protected even in remote locations with limited healthcare access.
Provides durable immunity with booster doses recommended every 3–5 years for individuals at continuous risk.
Find answers to common questions about the Anti-Rabies (Post-Exposure) vaccine, including when it’s needed and how it protects you.
PrEP involves receiving anti-rabies vaccines before exposure to provide immunity against rabies, primarily for individuals at higher risk.
High-risk groups, including veterinarians, wildlife workers, frequent travelers to rabies-endemic areas, and children living in high-risk regions, should consider PrEP.
The standard PrEP regimen includes 3 doses given on Days 0, 7, and 21 or 28. Booster doses are recommended for ongoing risk every 3–5 years.
Yes, but vaccinated individuals only need 2 doses of the rabies vaccine on Days 0 and 3 instead of the full PEP series, and RIG is not required.
Yes, the rabies vaccine is safe, with most side effects limited to mild pain, swelling, or redness at the injection site.
Immunity can last several years. Booster shots are recommended based on risk levels and periodic antibody checks.
Yes, children at higher risk, particularly in endemic areas, can and should receive PrEP.
If you have minimal exposure to animals, PrEP may not be necessary. Consult a healthcare provider to assess your risk.
Coverage varies; check with your provider. Many insurance plans cover PrEP for high-risk individuals.
Yes, the rabies vaccine does not require downtime. Ensure all doses are completed before travel for optimal protection.
Find answers to common questions about the Anti-Rabies (Post-Exposure) vaccine, including when it’s needed and how it protects you.
PrEP involves receiving anti-rabies vaccines before exposure to provide immunity against rabies, primarily for individuals at higher risk.
High-risk groups, including veterinarians, wildlife workers, frequent travelers to rabies-endemic areas, and children living in high-risk regions, should consider PrEP.
The standard PrEP regimen includes 3 doses given on Days 0, 7, and 21 or 28. Booster doses are recommended for ongoing risk every 3–5 years.
Yes, but vaccinated individuals only need 2 doses of the rabies vaccine on Days 0 and 3 instead of the full PEP series, and RIG is not required.
Yes, the rabies vaccine is safe, with most side effects limited to mild pain, swelling, or redness at the injection site.
Immunity can last several years. Booster shots are recommended based on risk levels and periodic antibody checks.
Yes, children at higher risk, particularly in endemic areas, can and should receive PrEP.
If you have minimal exposure to animals, PrEP may not be necessary. Consult a healthcare provider to assess your risk.
Coverage varies; check with your provider. Many insurance plans cover PrEP for high-risk individuals.
Yes, the rabies vaccine does not require downtime. Ensure all doses are completed before travel for optimal protection.
It’s better to be safe than sorry.
Book your vaccination today!
The Anti-Tetanus Vaccine is administered following an injury that may have exposed a person to the tetanus bacteria, commonly found in soil, dust, and manure.
Learn more about:
Recommended for: Individuals exposed to potential tetanus sources through wounds or injuries, those in high-risk environments, children, and travelers to rural areas.
Disease prevented: Tetanus
Price:
₱300.00
The Anti-Tetanus Vaccine is administered following an injury that may have exposed a person to the tetanus bacteria, commonly found in soil, dust, and manure. This vaccine helps the body develop immunity by producing antibodies that neutralize the toxins produced by the bacteria, preventing severe complications like muscle stiffness and spasms.
₱300.00
The Anti-Tetanus Vaccine is administered following an injury that may have exposed a person to the tetanus bacteria, commonly found in soil, dust, and manure. This vaccine helps the body develop immunity by producing antibodies that neutralize the toxins produced by the bacteria, preventing severe complications like muscle stiffness and spasms.
Find the Nearest SureVax Location:
The vaccine stops the spread of the tetanus toxin, which causes muscle tension and difficulty swallowing which can be life-threatening if untreated.
Given promptly after exposure, the vaccine helps produce antibodies that quickly act against the tetanus bacteria. Timely administration is critical for its effectiveness.
Safe and well-tolerated, with mild side effects like soreness at the injection site and temporary fatigue. Severe reactions are extremely rare.
Requires a booster every 10 years, as immunity from the initial vaccine can diminish over time. Boosters are essential to maintain lasting protection.
Should you get vaccinated? Who should consider getting a tetanus vaccine?
Ideal for anyone who frequently experiences cuts, scrapes, or punctures, especially gardeners, construction workers, and outdoor enthusiasts. A quick response post-injury is essential.
Vital for people working in high-risk environments like farms, industrial sites, or labs where they might come into contact with soil, animal waste, or rusty equipment.
Recommended for young children who play outdoors and their caregivers. Children are especially vulnerable due to frequent minor injuries and outdoor play.
Crucial for those traveling to remote or rural areas where medical help might be limited. The vaccine provides peace of mind against unexpected injuries far from healthcare facilities.
As tetanus immunity fades, all adults should get a booster shot every 10 years to stay protected, even without a recent injury.
Should you get vaccinated? Who should consider getting a tetanus vaccine?
For the Accident-Prone
Ideal for anyone who frequently experiences cuts, scrapes, or punctures, especially gardeners, construction workers, and outdoor enthusiasts. A quick response post-injury is essential.
Lifesaver for
High-Risk Environments
Vital for people working in high-risk environments like farms, industrial sites, or labs where they might come into contact with soil, animal waste, or rusty equipment.
Protection for Active Kids
and Caregivers
Recommended for young children who play outdoors and their caregivers. Children are especially vulnerable due to frequent minor injuries and outdoor play.
Safeguard for Travelers to
Rural or Remote Areas
Crucial for those traveling to remote or rural areas where medical help might be limited. The vaccine provides peace of mind against unexpected injuries far from healthcare facilities.
Routine Maintenance for All
As tetanus immunity fades, all adults should get a booster shot every 10 years to stay protected, even without a recent injury.
Protects against severe tetanus infections, preventing muscle stiffness and spasms while safeguarding overall health after injuries.
Quickly stimulates the immune system to fight off tetanus bacteria, preventing the development of serious infections. This immediate protection helps avoid severe muscle spasms and potential complications.
Minimizes the risk of infection from everyday cuts, scrapes, or puncture wounds, especially those exposed to dirt or rusty surfaces. With this safeguard, individuals can recover without the worry of tetanus.
Provides protection for up to ten years, ensuring lasting peace of mind and security against tetanus. Regular boosters maintain this immunity, offering reassurance in daily activities and unexpected injuries.
Ideal for those in construction, farming, and outdoor recreation who may frequently face injury risks. This vaccine helps keep high-risk individuals protected during their routine activities.
Young children, who are more prone to injuries while playing outdoors, are better protected with the anti-tetanus vaccine. Parents and caregivers gain peace of mind knowing that kids are safe from this serious bacterial infection.
Protects against severe tetanus infections, preventing muscle stiffness and spasms while safeguarding overall health after injuries.
Quickly stimulates the immune system to fight off tetanus bacteria, preventing the development of serious infections. This immediate protection helps avoid severe muscle spasms and potential complications.
Minimizes the risk of infection from everyday cuts, scrapes, or puncture wounds, especially those exposed to dirt or rusty surfaces. With this safeguard, individuals can recover without the worry of tetanus.
Provides protection for up to ten years, ensuring lasting peace of mind and security against tetanus. Regular boosters maintain this immunity, offering reassurance in daily activities and unexpected injuries.
Ideal for those in construction, farming, and outdoor recreation who may frequently face injury risks. This vaccine helps keep high-risk individuals protected during their routine activities.
Young children, who are more prone to injuries while playing outdoors, are better protected with the anti-tetanus vaccine. Parents and caregivers gain peace of mind knowing that kids are safe from this serious bacterial infection.
Discover key information about the Anti-Tetanus vaccine, including who should get it and how it helps prevent serious infections.
The anti-tetanus vaccine protects against Clostridium tetani, the bacteria that causes tetanus, a potentially fatal condition characterized by muscle stiffness and spasms.
Anyone who has had chickenpox is at risk since the virus can remain dormant and reactivate as shingles. The risk increases with age, especially for those 50 and older.
Symptoms typically start with pain, tingling, or itching on one side of the body, followed by a rash that turns into painful blisters. Fever, headache, and fatigue may also occur.
The vaccine is highly effective, reducing the risk of shingles by over 90% in most adults and providing long-lasting protection.
Tetanus toxoid is the component of the vaccine that helps your body build immunity against the tetanus toxin.
While rare, breakthrough cases can occur if boosters are not up to date, or if a person has an extremely high-risk exposure and a weak immune response.
You may need a tetanus booster shot and, in some cases, tetanus immunoglobulin (TIG) for immediate protection. Consult a healthcare provider promptly.
Yes, it is safe and well-tolerated. Mild side effects include soreness at the injection site, fever, or fatigue.
People who have had a severe allergic reaction to a previous tetanus vaccine dose or any vaccine component should consult their doctor before getting the vaccine.
Protection lasts about 10 years after the last booster dose. After that, a booster is needed to maintain immunity.
Discover key information about the Anti-Tetanus vaccine, including who should get it and how it helps prevent serious infections.
The anti-tetanus vaccine protects against Clostridium tetani, the bacteria that causes tetanus, a potentially fatal condition characterized by muscle stiffness and spasms.
You need the vaccine if you have a deep or dirty wound and have not had a tetanus shot in the last 5 years. It’s also part of routine childhood immunization and booster schedules.
The vaccine stimulates your immune system to produce antibodies that protect against tetanus. It doesn’t provide instant immunity, so immediate care for wounds is crucial.
The primary series includes 3 doses, typically given in combination with diphtheria and pertussis (DTaP or Tdap). Boosters are recommended every 10 years.
Tetanus toxoid is the component of the vaccine that helps your body build immunity against the tetanus toxin.
While rare, breakthrough cases can occur if boosters are not up to date, or if a person has an extremely high-risk exposure and a weak immune response.
You may need a tetanus booster shot and, in some cases, tetanus immunoglobulin (TIG) for immediate protection. Consult a healthcare provider promptly.
Yes, it is safe and well-tolerated. Mild side effects include soreness at the injection site, fever, or fatigue.
People who have had a severe allergic reaction to a previous tetanus vaccine dose or any vaccine component should consult their doctor before getting the vaccine.
Protection lasts about 10 years after the last booster dose. After that, a booster is needed to maintain immunity.
It’s better to be safe than sorry.
Book your vaccination today!
The Quadrivalent Flu Vaccine provides protection against four common flu strains, including two influenza A and two influenza B strains, offering
Learn more about:
Recommended for: Individuals at risk of flu complications, those with frequent exposure to others, young children, elderly adults, and travelers during flu season.
Disease prevented: Influenza
Price:
₱1,200.00
The Quadrivalent Flu Vaccine provides protection against four common flu strains, including two influenza A and two influenza B strains, offering comprehensive coverage. By reducing the risk of flu-related illness, it plays a vital role in keeping communities healthier, especially during flu season.
₱1,200.00
The Quadrivalent Flu Vaccine provides protection against four common flu strains, including two influenza A and two influenza B strains, offering comprehensive coverage. By reducing the risk of flu-related illness, it plays a vital role in keeping communities healthier, especially during flu season.
Find the Nearest SureVax Location:
Broader protection compared to trivalent vaccines, the quadrivalent vaccine targets an additional influenza B strain, enhancing immunity against seasonal variants.
Mild side effects are common, such as soreness at the injection site or mild fatigue. Serious reactions are rare, making the vaccine safe for most people.
Annual administration is necessary due to the flu virus’s ability to change year by year. Each updated vaccine targets the latest flu strains, providing the best available immunity.
Who benefits most from the flu vaccine? Should you get vaccinated?
People with chronic conditions, such as asthma, diabetes, or heart disease, are more susceptible to severe flu complications. The flu vaccine helps reduce hospitalization rates and flu severity in these individuals, providing essential protection during flu season.
Healthcare workers and caregivers frequently interact with individuals at risk of serious flu complications. Vaccination is a safeguard that prevents the flu from spreading in healthcare settings, protecting both caregivers and those they look after.
Young children and older adults face increased risks from the flu, including complications that can lead to hospitalization. The flu vaccine strengthens their immune response, helping them avoid the worst symptoms and reduce the chance of severe outcomes.
In settings like schools, offices, dormitories, and group housing, where viruses spread easily, the flu vaccine significantly lowers the chance of outbreaks. Vaccinated individuals help maintain a healthier environment, with fewer flu-related absences and lower transmission rates.
Travelers during flu season often encounter diverse flu strains and have increased exposure in crowded places like airports. The flu vaccine reduces the risk of contracting or spreading the virus across regions, ensuring travelers stay healthier on the go.
Who benefits most from the flu vaccine? Should you get vaccinated?
Chronic Health Conditions
People with chronic conditions, such as asthma, diabetes, or heart disease, are more susceptible to severe flu complications. The flu vaccine helps reduce hospitalization rates and flu severity in these individuals, providing essential protection during flu season.
Healthcare and Caregiving
Professions
Healthcare workers and caregivers frequently interact with individuals at risk of serious flu complications. Vaccination is a safeguard that prevents the flu from spreading in healthcare settings, protecting both caregivers and those they look after.
Children and Older Adults
Young children and older adults face increased risks from the flu, including complications that can lead to hospitalization. The flu vaccine strengthens their immune response, helping them avoid the worst symptoms and reduce the chance of severe outcomes.
Close-Contact Environments
In settings like schools, offices, dormitories, and group housing, where viruses spread easily, the flu vaccine significantly lowers the chance of outbreaks. Vaccinated individuals help maintain a healthier environment, with fewer flu-related absences and lower transmission rates.
Frequent Travelers
Travelers during flu season often encounter diverse flu strains and have increased exposure in crowded places like airports. The flu vaccine reduces the risk of contracting or spreading the virus across regions, ensuring travelers stay healthier on the go.
The Flu Vaccine (Quadrivalent) offers broad protection against four strains of influenza, reducing the risk of seasonal flu and promoting a healthier, more resilient immune system.
Lowers the chances of contracting the flu and helps prevent severe symptoms if infected. This protection reduces the likelihood of complications and speeds up recovery.
Offers essential defense for people with weaker immune systems, such as young children, seniors, and those with chronic health conditions. By getting vaccinated, you help protect yourself and others who are more susceptible to illness.
Reduces missed days at work, school, and other important activities due to flu-related illness. With fewer interruptions, you can maintain productivity and enjoy more uninterrupted time with family and friends.
Contributes to herd immunity, lowering the spread of flu within communities, workplaces, and schools. This added layer of protection benefits everyone by reducing overall flu cases.
Provides mental reassurance during flu season, reducing anxiety about potential illness. By taking this preventive step, you can feel more confident in public spaces and social settings.
The Flu Vaccine (Quadrivalent) offers broad protection against four strains of influenza, reducing the risk of seasonal flu and promoting a healthier, more resilient immune system.
Lowers the chances of contracting the flu and helps prevent severe symptoms if infected. This protection reduces the likelihood of complications and speeds up recovery.
Offers essential defense for people with weaker immune systems, such as young children, seniors, and those with chronic health conditions. By getting vaccinated, you help protect yourself and others who are more susceptible to illness.
Reduces missed days at work, school, and other important activities due to flu-related illness. With fewer interruptions, you can maintain productivity and enjoy more uninterrupted time with family and friends.
Contributes to herd immunity, lowering the spread of flu within communities, workplaces, and schools. This added layer of protection benefits everyone by reducing overall flu cases.
Provides mental reassurance during flu season, reducing anxiety about potential illness. By taking this preventive step, you can feel more confident in public spaces and social settings.
Find answers to common questions about the Flu vaccine, including who benefits and what to expect.
A quadrivalent flu vaccine protects against four different influenza viruses: two influenza A viruses and two influenza B viruses. This provides broader protection compared to trivalent vaccines that only cover three strains.
The CDC recommends annual flu vaccination for everyone 6 months and older, with rare exceptions. It's especially important for:
● People 65 years and older
● Pregnant women
● People with chronic health conditions
● Healthcare workers
● Caregivers of high-risk individuals
Get vaccinated before flu season begins, ideally by the end of October. However, vaccination can continue throughout flu season, even into January or later.
What are the common side effects? Most side effects are mild and resolve within a few days:
● Soreness, redness, and swelling at injection site
● Low-grade fever
● Mild muscle aches
● Headache
● Fatigue
No. The flu vaccine cannot cause flu illness. The viruses in flu shots are either killed (inactivated) or significantly weakened (attenuated), making them unable to cause infection.
Effectiveness varies year to year, typically reducing flu risk by 40-60% when the vaccine matches circulating strains well. Even if you get flu after vaccination, symptoms are usually milder.
Consult your healthcare provider if you:
● Have severe, life-threatening allergies to vaccine ingredients
● Had a severe reaction to a previous flu vaccine
● Have ever had Guillain-Barré Syndrome
● Are currently feeling ill with fever
Protection lasts throughout the flu season but gradually decreases over time. Annual vaccination is needed because:
● Flu viruses constantly change
● Immune protection naturally declines
● Vaccine composition is updated annually
Yes, it's safe to get the flu vaccine at the same time as other vaccines, including COVID-19 vaccines. Different injection sites will be used.
Find answers to common questions about the Flu vaccine, including who benefits and what to expect.
A quadrivalent flu vaccine protects against four different influenza viruses: two influenza A viruses and two influenza B viruses. This provides broader protection compared to trivalent vaccines that only cover three strains.
The CDC recommends annual flu vaccination for everyone 6 months and older, with rare exceptions. It's especially important for:
Get vaccinated before flu season begins, ideally by the end of October. However, vaccination can continue throughout flu season, even into January or later.
What are the common side effects? Most side effects are mild and resolve within a few days:
<ul
No. The flu vaccine cannot cause flu illness. The viruses in flu shots are either killed (inactivated) or significantly weakened (attenuated), making them unable to cause infection.
Effectiveness varies year to year, typically reducing flu risk by 40-60% when the vaccine matches circulating strains well. Even if you get flu after vaccination, symptoms are usually milder.
Consult your healthcare provider if you:
<ul
Protection lasts throughout the flu season but gradually decreases over time. Annual vaccination is needed because:
<ul
Yes, it's safe to get the flu vaccine at the same time as other vaccines, including COVID-19 vaccines. Different injection sites will be used.
It’s better to be safe than sorry.
Book your vaccination today!
Should you get vaccinated? Who should consider the HPV vaccine and why?
Learn more about:
Recommended for: Individuals at risk of HPV-related diseases, especially young people before exposure to HPV, and those with a higher risk of infection or complications.
Disease prevented: HPV-related cancers
Price:
₱3,800.00
The HPV-4 vaccine protects against four major strains of the human papillomavirus (HPV), which are responsible for most cases of cervical cancer, as well as other types of cancer and genital warts. It significantly reduces the risk of HPV-related illnesses and is a key preventive measure, especially for those in their teens and early adulthood.
₱3,800.00
The HPV-4 vaccine protects against four major strains of the human papillomavirus (HPV), which are responsible for most cases of cervical cancer, as well as other types of cancer and genital warts. It significantly reduces the risk of HPV-related illnesses and is a key preventive measure, especially for those in their teens and early adulthood.
Find the Nearest SureVax Location:
The HPV vaccine guards against cervical, anal, and other genital cancers, along with genital warts. It targets high-risk HPV strains that account for the majority of HPV-related cancers.
The quadrivalent HPV vaccine covers two HPV strains linked to cancer and two strains that cause genital warts, offering broad protection against both.
Safe and well-tolerated, with common side effects like mild soreness at the injection site or temporary dizziness. Severe reactions are extremely rare.
Optimal protection is achieved before HPV exposure, so the vaccine is typically recommended for preteens and young adults, though older individuals can still benefit if not previously vaccinated.
Should you get vaccinated? Who should consider the HPV vaccine and why?
Vaccinating at a young age, typically between 9 and 14, ensures protection before any exposure to HPV. Since the immune response is stronger in younger individuals, early vaccination provides lasting immunity and lowers future risks of HPV-related cancers and infections.
For individuals in their teens and early 20s who may not have had prior exposure, the HPV vaccine offers valuable protection as they reach an age where HPV exposure becomes more likely. The vaccine reduces the chance of infection and its associated health risks, including cancers and genital warts.
For immunocompromised individuals or those with health conditions that increase cancer risk, the HPV vaccine provides a crucial preventive measure. It lowers the likelihood of severe HPV-related complications, helping maintain better long-term health.
People with new or multiple partners, or those whose partners may be at risk, can benefit significantly from the vaccine’s preventive protection. By reducing HPV transmission, vaccination also helps protect partners and minimizes the spread of the virus within close relationships.
Healthcare professionals, especially those who may encounter HPV-positive patients, gain valuable protection with the HPV vaccine. Reducing their risk of infection also supports the broader goal of community health and reduces transmission rates.
Should you get vaccinated? Who should consider the HPV vaccine and why?
Preteens and Adolescents
Vaccinating at a young age, typically between 9 and 14, ensures protection before any exposure to HPV. Since the immune response is stronger in younger individuals, early vaccination provides lasting immunity and lowers future risks of HPV-related cancers and infections.
Young Adults
For individuals in their teens and early 20s who may not have had prior exposure, the HPV vaccine offers valuable protection as they reach an age where HPV exposure becomes more likely. The vaccine reduces the chance of infection and its associated health risks, including cancers and genital warts.
Those with a Higher Risk of
HPV Complications
For immunocompromised individuals or those with health conditions that increase cancer risk, the HPV vaccine provides a crucial preventive measure. It lowers the likelihood of severe HPV-related complications, helping maintain better long-term health.
Partners and Spouses
People with new or multiple partners, or those whose partners may be at risk, can benefit significantly from the vaccine’s preventive protection. By reducing HPV transmission, vaccination also helps protect partners and minimizes the spread of the virus within close relationships.
Healthcare and
Public Health Workers
Healthcare professionals, especially those who may encounter HPV-positive patients, gain valuable protection with the HPV vaccine. Reducing their risk of infection also supports the broader goal of community health and reduces transmission rates.
The Flu Vaccine (Quadrivalent) offers broad protection against four strains of influenza, reducing the risk of seasonal flu and promoting a healthier, more resilient immune system.
The HPV vaccine significantly reduces the risk of HPV-related cancers, including cervical, throat, and genital cancers.
Widespread vaccination helps reduce the overall prevalence of HPV in the population, creating herd immunity and lowering transmission rates.
The vaccine reduces the stress and worry about contracting HPV-related diseases, allowing people to feel more secure in their health.
The vaccine empowers individuals to take proactive steps in protecting their health, which can contribute to an overall sense of well-being and responsibility.
The vaccine benefits all genders, offering protection across diverse populations and helping to reduce stigma associated with HPV.
The HPV-4 vaccine guards against four common strains of HPV, significantly lowering the risk of cervical cancer and other HPV-related conditions.
The HPV vaccine significantly reduces the risk of HPV-related cancers, including cervical, throat, and genital cancers.
Widespread vaccination helps reduce the overall prevalence of HPV in the population, creating herd immunity and lowering transmission rates.
The vaccine reduces the stress and worry about contracting HPV-related diseases, allowing people to feel more secure in their health.
The vaccine empowers individuals to take proactive steps in protecting their health, which can contribute to an overall sense of well-being and responsibility.
The vaccine benefits all genders, offering protection across diverse populations and helping to reduce stigma associated with HPV.
Learn more about the HPV-4 vaccine, including who it’s for and how it protects against HPV-related diseases.
The HPV-4 vaccine (Gardasil) protects against four types of human papillomavirus (HPV): types 6, 11, 16, and 18. These strains are responsible for most cases of cervical cancer and genital warts.
● Recommended for all adolescents aged 11-12 years
● Catch-up vaccination available for:
● Females aged 13-26 years
● Males aged 13-21 years
● Men who have sex with men through age 26
● Immunocompromised individuals through age 26
The vaccine is given as three separate shots over 6 months:
● First dose: Initial vaccination
● Second dose: 2 months after first dose
● Third dose: 6 months after first dose
● Prevents up to 90% of cervical cancers
● Prevents 90% of genital warts
● Protects against several other HPV-related cancers
● Provides long-lasting immunity
Most side effects are mild and include: ● Pain at injection site
● Swelling and redness
● Mild fever
● Headache
● Fatigue
Yes. The vaccine has been extensively tested and monitored since its approval in 2006. Over 270 million doses have been administered worldwide with a strong safety record.
Most private insurance plans cover the vaccine for recommended age groups. The Vaccines for Children (VFC) program provides free vaccines to eligible children. Check with your insurance provider or local health department for coverage details.
No. The vaccine contains virus-like particles but no live virus, making it impossible to get HPV from vaccination.
Yes. Vaccinated individuals should still get regular cervical cancer screening as recommended by their healthcare provider, as the vaccine doesn't protect against all HPV types that can cause cancer.
If you miss a dose, you don't need to restart the series. Schedule the missed dose as soon as possible and complete the remaining doses according to the recommended schedule.
Learn more about the HPV-4 vaccine, including who it’s for and how it protects against HPV-related diseases.
The HPV-4 vaccine (Gardasil) protects against four types of human papillomavirus (HPV): types 6, 11, 16, and 18. These strains are responsible for most cases of cervical cancer and genital warts.
<ul
The vaccine is given as three separate shots over 6 months:
Consult your healthcare provider if you:
Most side effects are mild and include:
Yes. The vaccine has been extensively tested and monitored since its approval in 2006. Over 270 million doses have been administered worldwide with a strong safety record.
Most private insurance plans cover the vaccine for recommended age groups. The Vaccines for Children (VFC) program provides free vaccines to eligible children. Check with your insurance provider or local health department for coverage details.
No. The vaccine contains virus-like particles but no live virus, making it impossible to get HPV from vaccination.
Yes. Vaccinated individuals should still get regular cervical cancer screening as recommended by their healthcare provider, as the vaccine doesn't protect against all HPV types that can cause cancer.
If you miss a dose, you don't need to restart the series. Schedule the missed dose as soon as possible and complete the remaining doses according to the recommended schedule.
It’s better to be safe than sorry.
Book your vaccination today!
The Pneumonia Vaccine (PCV13) protects against 13 strains of pneumococcal bacteria, reducing the risk of serious infections like pneumonia, meningitis, and
Learn more about:
Recommended for: Those at elevated risk of pneumonia and related infections, including children, older adults, and individuals with certain health conditions or lifestyle factors.
Disease prevented: Pneumococcal disease
Price:
₱4,000.00
The PCV13 Vaccine protects against 13 strains of pneumococcal bacteria, which can cause serious infections such as pneumonia, meningitis, and bloodstream infections. It significantly reduces the risk of severe pneumococcal diseases and is an essential preventive measure, especially for young children, older adults, and individuals with weakened immune systems.
₱3,000.00
The Quadrivalent Flu Vaccine provides protection against four common flu strains, including two influenza A and two influenza B strains, offering comprehensive coverage. By reducing the risk of flu-related illness, it plays a vital role in keeping communities healthier, especially during flu season.
Find the Nearest SureVax Location:
Covers 13 different strains, providing broad and reliable protection against common pneumococcal bacteria. This extensive coverage is key to preventing respiratory-related hospitalizations and complications.
Safe and well-tolerated, with mild side effects like arm soreness or low-grade fever. Serious adverse effects are rare.
Targeted toward those with the highest risks for pneumococcal infections, including children, seniors, and people with underlying health concerns.
Who should receive the PCV13 vaccine? When should you get vaccinated?
Young children, especially those under five, are at high risk for severe pneumococcal infections due to developing immune systems. The PCV13 vaccine can prevent early childhood respiratory infections that may lead to meningitis or ear infections, ensuring healthier development during crucial growth stages.
Individuals with chronic health issues like diabetes, asthma, COPD, or heart disease face heightened risks if they contract pneumococcal infections. PCV13 helps safeguard those with compromised immunity, preventing illnesses that could worsen their conditions or lead to prolonged hospital stays.
For people living in close quarters, such as nursing homes, long-term care facilities, or dormitories, pneumococcal bacteria can spread easily. The PCV13 vaccine lowers the risk of respiratory outbreaks, protecting both the vaccinated individual and those in their community from serious infections.
Immunity weakens with age, making older adults more susceptible to pneumonia and other pneumococcal diseases. PCV13 offers essential protection for seniors, reducing the risk of hospitalization and severe complications that could impact quality of life and independence.
For those undergoing surgeries or treatments that may weaken their immune systems, such as chemotherapy or organ transplants, PCV13 provides an added layer of defense. Vaccination before such interventions can prevent complications from pneumococcal infections during recovery.
Who should receive the PCV13 vaccine? When should you get vaccinated?
Early Years
(Infants and Young Children)
Young children, especially those under five, are at high risk for severe pneumococcal infections due to developing immune systems. The PCV13 vaccine can prevent early childhood respiratory infections that may lead to meningitis or ear infections, ensuring healthier development during crucial growth stages.
Health Vulnerabilities
(Chronic Conditions)
Individuals with chronic health issues like diabetes, asthma, COPD, or heart disease face heightened risks if they contract pneumococcal infections. PCV13 helps safeguard those with compromised immunity, preventing illnesses that could worsen their conditions or lead to prolonged hospital stays.
Increased Exposure (Crowded
or High-Contact Environments)
For people living in close quarters, such as nursing homes, long-term care facilities, or dormitories, pneumococcal bacteria can spread easily. The PCV13 vaccine lowers the risk of respiratory outbreaks, protecting both the vaccinated individual and those in their community from serious infections.
Advanced Age (Seniors 65+)
Immunity weakens with age, making older adults more susceptible to pneumonia and other pneumococcal diseases. PCV13 offers essential protection for seniors, reducing the risk of hospitalization and severe complications that could impact quality of life and independence.
Medical Interventions
(Surgical Patients and
Immunosuppressive Treatments)
For those undergoing surgeries or treatments that may weaken their immune systems, such as chemotherapy or organ transplants, PCV13 provides an added layer of defense. Vaccination before such interventions can prevent complications from pneumococcal infections during recovery.
The Pneumonia Vaccine (PCV13) protects against 13 strains of pneumococcal bacteria, reducing the risk of serious infections like pneumonia, meningitis, and sepsis for long-term health benefits.
Significantly lowers the chances of developing serious forms of pneumonia and its complications, such as sepsis or respiratory failure.
Minimizes hospitalizations, ER visits, and doctor appointments, leading to fewer disruptions in daily life and less strain on healthcare systems.
Widespread vaccination reduces overall transmission, protecting those unable to get vaccinated and supporting community health.
Reduces the worry of frequent respiratory infections and promotes a more active, worry-free lifestyle, especially for older adults.
Reduces costs associated with medical treatment for pneumonia, including lost wages, transportation, and prescription medications.
The Pneumonia Vaccine (PCV13) protects against 13 strains of pneumococcal bacteria, reducing the risk of serious infections like pneumonia, meningitis, and sepsis for long-term health benefits.
Significantly lowers the chances of developing serious forms of pneumonia and its complications, such as sepsis or respiratory failure.
Minimizes hospitalizations, ER visits, and doctor appointments, leading to fewer disruptions in daily life and less strain on healthcare systems.
Widespread vaccination reduces overall transmission, protecting those unable to get vaccinated and supporting community health.
Reduces the worry of frequent respiratory infections and promotes a more active, worry-free lifestyle, especially for older adults.
Reduces costs associated with medical treatment for pneumonia, including lost wages, transportation, and prescription medications.
Learn more about the HPV-4 vaccine, including who it’s for and how it protects against HPV-related diseases.
PCV13 (Prevnar 13®) is a vaccine that protects against 13 types of pneumococcal bacteria that can cause serious infections like pneumonia, meningitis, and bloodstream infections.
● All children under 2 years old
● Adults 65 years or older (discuss with healthcare provider)
● People 2-64 years with certain medical conditions that increase risk
● Immunocompromised individuals
For children:
● 2 months: First dose
● 4 months: Second dose
● 6 months: Third dose
● 12-15 months: Fourth dose (booster)
For adults 65+:
● Single dose
● May need additional pneumococcal vaccines (PPSV23) based on provider recommendation
● Injection site reactions: redness, swelling, pain
● Mild fever
● Irritability in children
● Fatigue
● Headache
● Muscle aches
● Reduced appetite (in children)
Severe allergic reactions are rare but possible. Seek immediate medical attention if experiencing:
● Difficulty breathing
● Rapid heartbeat
● Dizziness
● High fever
● Severe skin rash
Severe allergic reactions are rare but possible. Seek immediate medical attention if experiencing:
1. Anyone with severe allergic reaction to previous dose
2. Individuals allergic to any vaccine components
3. Those with severe illness (mild illnesses are okay)
Yes, PCV13 can be administered with other vaccines during the same visit at different injection sites.
Most insurance plans cover PCV13. Medicare Part B covers pneumococcal vaccines for adults 65+. Check with your provider for specific coverage details.
Protection is long-lasting. Most people don't need additional doses beyond the recommended schedule unless they have specific medical conditions.
● Primary care physician offices
● Pediatrician offices
● Pharmacies
● Local health departments
● Travel clinics
Healthcare providers must store PCV13 in a refrigerator between 36°F and 46°F (2°C to 8°C). Do not freeze.
Find answers to your questions about the PCV13 vaccine, including who should receive it and what it protects against.
PCV13 (Prevnar 13®) is a vaccine that protects against 13 types of pneumococcal bacteria that can cause serious infections like pneumonia, meningitis, and bloodstream infections.
For children:
Severe allergic reactions are rare but possible. Seek immediate medical attention if experiencing:
Yes, PCV13 can be administered with other vaccines during the same visit at different injection sites.
Most insurance plans cover PCV13. Medicare Part B covers pneumococcal vaccines for adults 65+. Check with your provider for specific coverage details.
Protection is long-lasting. Most people don't need additional doses beyond the recommended schedule unless they have specific medical conditions.
Healthcare providers must store PCV13 in a refrigerator between 36°F and 46°F (2°C to 8°C). Do not freeze.
It’s better to be safe than sorry.
Book your vaccination today!
Recommended for: Adults over 50, those with weakened immune systems, and anyone with a history of chickenpox to help prevent shingles and its painful
Learn more about:
Recommended for: Adults over 50, those with weakened immune systems, and anyone with a history of chickenpox to help prevent shingles and its painful complications.
Disease prevented: Shingles
Price:
₱10,000.00
The Shingles Vaccine is designed to protect against shingles, a painful skin rash caused by the reactivation of the varicella-zoster virus. This vaccine helps prevent complications like postherpetic neuralgia, a long-lasting nerve pain that can follow shingles. By reducing the risk of shingles and its associated discomfort, it supports healthier aging and improved quality of life for adults, especially those 50 and older.
₱12,000.00
The Shingles Vaccine is designed to protect against shingles, a painful skin rash caused by the reactivation of the varicella-zoster virus. This vaccine helps prevent complications like postherpetic neuralgia, a long-lasting nerve pain that can follow shingles. By reducing the risk of shingles and its associated discomfort, it supports healthier aging and improved quality of life for adults, especially those 50 and older.
Find the Nearest SureVax Location:
The shingles vaccine is known to provide long-lasting immunity, significantly lowering the risk of shingles outbreaks over time. It’s particularly effective for adults over 50, who are at increased risk of severe symptoms.
Common side effects include mild soreness or swelling at the injection site and occasional fatigue, which generally resolve within a few days. More serious side effects are rare, making it a safe option for most people.
The vaccine is especially recommended for individuals with weakened immune systems or chronic health conditions, as they face greater risks of severe complications from shingles.
Given the chance of long-term nerve pain (postherpetic neuralgia) from shingles, the vaccine helps prevent painful episodes, supporting better quality of life, particularly for older adults.
Who should prioritize the shingles vaccine? When is the best time to get vaccinated?
For individuals over 50, age naturally reduces immunity, increasing susceptibility to shingles. Vaccination offers a proactive layer of protection to prevent outbreaks as immunity declines.
People with diabetes, heart disease, or other chronic conditions are more prone to shingles complications. The vaccine provides these individuals with added resilience against potential outbreaks and painful complications.
For those recovering from major surgeries or undergoing immune-compromising treatments (like chemotherapy), the vaccine helps avoid shingles during critical recovery phases, minimizing health disruptions.
Healthcare workers and caregivers in close-contact settings benefit from the vaccine by reducing the chance of spreading the virus to vulnerable individuals they care for, providing peace of mind and enhanced community health.
Who should prioritize the shingles vaccine? When is the best time to get vaccinated?
Age-Related Immunity Support
Individuals over 50 whose immunity naturally declines with age
When signs of age-related immunity decline appear
Chronic Health Condition Defense
People with chronic conditions like diabetes or heart disease
Before risk of shingles complications increases
Immune Recovery Assistance
Those recovering from major surgeries or immune-compromising treatments
During or just prior to critical recovery phases
High-Contact Environment Safeguard
Healthcare workers and caregivers in close-contact settings
Before beginning or resuming high-contact duties
The shingles vaccine provides valuable protection, helping reduce the risk of a painful illness and supporting a healthier, more active life as we age.
The vaccine significantly lowers the chance of developing shingles, a painful rash that can last for weeks.
By preventing a painful condition, the vaccine can improve overall quality of life, reducing days lost to pain, discomfort, and restricted activities.
Knowing you're protected from a painful illness can provide peace of mind, reducing anxiety about potential health issues.
The vaccine helps avoid one of the more common illnesses that can affect aging adults, supporting a healthier and more active lifestyle.
By lowering the risk of shingles and its complications, the vaccine can reduce medical expenses and the need for treatments, lessening the burden on caregivers and families.
The shingles vaccine provides valuable protection, helping reduce the risk of a painful illness and supporting a healthier, more active life as we age.
The vaccine significantly lowers the chance of developing shingles, a painful rash that can last for weeks.
By preventing a painful condition, the vaccine can improve overall quality of life, reducing days lost to pain, discomfort, and restricted activities.
Knowing you're protected from a painful illness can provide peace of mind, reducing anxiety about potential health issues.
The vaccine helps avoid one of the more common illnesses that can affect aging adults, supporting a healthier and more active lifestyle.
By lowering the risk of shingles and its complications, the vaccine can reduce medical expenses and the need for treatments, lessening the burden on caregivers and families.
Find answers to common questions about the shingles vaccine, including who benefits and what to expect.
Shingles is a viral infection caused by the varicella-zoster virus, the same virus responsible for chickenpox. It results in a painful rash, often appearing as a stripe of blisters on one side of the body.
Anyone who has had chickenpox is at risk since the virus can remain dormant and reactivate as shingles. The risk increases with age, especially for those 50 and older.
Symptoms typically start with pain, tingling, or itching on one side of the body, followed by a rash that turns into painful blisters. Fever, headache, and fatigue may also occur.
The vaccine is highly effective, reducing the risk of shingles by over 90% in most adults and providing long-lasting protection.
Shingles usually last 2 to 4 weeks, but complications like postherpetic neuralgia (PHN)—long-lasting nerve pain—can persist for months or years.
Yes, although uncommon, it is possible to get shingles more than once. The shingles vaccine helps reduce the risk of recurrence.
PHN is a complication of shingles that involves severe, lasting nerve pain after the rash has healed, often impacting older adults.
The vaccine boosts the immune response to prevent the reactivation of the virus, reducing the risk of shingles and complications. It’s recommended for adults aged 50 and older, and for those 19 and older with weakened immune systems.
Common side effects include redness, swelling, or soreness at the injection site, as well as fatigue, headache, and mild fever. These effects are usually temporary.
Shingles itself isn’t contagious, but the varicella-zoster virus can spread through direct contact with the fluid from shingles blisters to someone who hasn’t had chickenpox, potentially causing chickenpox in that person.
Find answers to common questions about the shingles vaccine, including who benefits and what to expect.
The vaccine significantly lowers the chance of developing shingles, a painful rash that can last for weeks.
Anyone who has had chickenpox is at risk since the virus can remain dormant and reactivate as shingles. The risk increases with age, especially for those 50 and older.
Symptoms typically start with pain, tingling, or itching on one side of the body, followed by a rash that turns into painful blisters. Fever, headache, and fatigue may also occur.
The vaccine is highly effective, reducing the risk of shingles by over 90% in most adults and providing long-lasting protection.
Shingles usually lasts 2 to 4 weeks, but complications like postherpetic neuralgia (PHN)—a long-lasting nerve pain—can persist for months or years.
Yes, although uncommon, it is possible to get shingles more than once. The shingles vaccine helps reduce the risk of recurrence.
PHN is a complication of shingles that involves severe, lasting nerve pain after the rash has healed, often impacting older adults.
The vaccine boosts the immune response to prevent the reactivation of the virus, reducing the risk of shingles and complications. It’s recommended for adults aged 50 and older, and for those 19 and older with weakened immune systems.
Common side effects include redness, swelling, or soreness at the injection site, as well as fatigue, headache, and mild fever. These effects are usually temporary.
Shingles itself isn’t contagious, but the varicella-zoster virus can spread through direct contact with the fluid from shingles blisters to someone who hasn’t had chickenpox, potentially causing chickenpox in that person.
It’s better to be safe than sorry.
Book your vaccination today!